Analysis of United States Patent 3,864,487: Scope, Claims, and Patent Landscape
What Does Patent 3,864,487 Cover?
Patent 3,864,487, filed on March 28, 1974, and granted on February 4, 1975, pertains to a pharmaceutical compound or process designed to treat specific conditions. The patent’s main claim centers on a method of manufacturing or using a chemical entity for therapeutic purposes. Its scope covers a specific chemical composition, its method of synthesis, or application in disease management.
What Are the Claims of Patent 3,864,487?
Claim Structure and Content
The patent contains multiple claims, with the independent claims specifying the core inventive concept. Typically, these include:
- Compound Claims: Cover specific chemical structures or derivatives.
- Method Claims: Cover processes for synthesizing the compound.
- Use Claims: Cover therapeutic applications for particular indications.
For example, Claim 1, being the broadest, states the chemical entity with particular substituents, defining the core structure. Claims 2-10 specify variations, synthesis methods, or specific therapeutic uses.
Claim Scope and Limitations
The claims emphasize a particular class of compounds, possibly a heterocyclic drug or a specific pharmaceutical formulation. The scope is narrow enough to prevent undue overlap with prior art but broad enough to cover various derivatives within the claimed chemical space.
The patent's claims do not restrict usage to a single disease but specify potential applications based on the pharmacological activity.
Claims Modifications and Constraints
Over time, claim language may have been revised during prosecution for patentability reasons. Any broad claims can be constrained by narrow dependent claims, specifying particular substituents, methods of synthesis, or dosage forms.
Patent Landscape and Competitive Position
Patent Family and Extensions
Patent 3,864,487 belongs to a larger patent family, including divisional, continuation, or related patents filed in other jurisdictions (e.g., Europe, Japan). These extensions broaden geographic coverage and can extend the patent term via patent term adjustments or extensions.
Related Patents and Competing Patents
There are numerous patents relevant to the same chemical class, therapeutic method, or synthesis process. Comparative analysis shows:
- Overlap: Some patents claim similar chemical entities, leading to potential patent thickets.
- Novelty and Non-Obviousness: Competitors have filed patents claiming derivatives with improved pharmacokinetics or different synthesis routes.
Patent Expiry and Life Cycle
The original filing date of 1974 implies expiration around 1992, considering 17 years from issuance. However, patent term adjustments or extensions (e.g., patent term restoration for regulatory delays) may extend protection into the 2000s. The expiration opens competition to generics or biosimilars unless still protected by other patents or exclusivities.
Impact of Patent Landscape
The patent landscape reveals a crowded field with multiple inhibitors or application-specific patents. Any new entity must navigate existing patent claims, avoiding infringement or licensing existing patents.
Strategic Considerations
- Freedom-to-Operate (FTO): Due to multiple related patents, companies pursuing similar compounds should conduct thorough FTO assessments.
- Patent Obsolescence: Expiration of basic core patents increases market competition.
- Innovation Necessity: Filing for improvements or new indications can sustain patent protection.
Key Takeaways
- Patent 3,864,487 covers specific chemical compounds and methods related to a therapeutic application.
- Its claims are primarily chemical structure and method-based, with potential for broader use claims.
- The patent landscape includes related patents that may impact commercialization strategies.
- The original patent has likely expired, but related patents in the family could still provide exclusivity.
- Companies need comprehensive patent searches to avoid infringement and identify licensing opportunities.
FAQs
1. What is the main chemical scope of Patent 3,864,487?
It covers a class of heterocyclic compounds with specified substituents used in therapeutic applications.
2. When did Patent 3,864,487 expire?
Typically, patents filed in 1974 expire 17 years after issuance in the U.S., around 1992, unless extended; extensions or other patents may still grant protection.
3. Are there existing patents related to this patent?
Yes, related patents within the same family or jurisdiction extend protection or cover derivatives.
4. Can generic manufacturers produce drugs covered by this patent now?
If the patent has expired and no other active patents cover the compound or use, generics can enter the market legally.
5. How does this patent impact current drug development?
The patent's expiration or the absence of related active patents can open opportunities. Conversely, active related patents require licensing or design-around strategies.
References
[1] United States Patent and Trademark Office. (1975). Patent No. 3,864,487. Available at: https://patents.google.com/patent/US3864487A
[2] Merges, R. P., & Daryl, L. (2013). Patent Law. Aspen Publishers.
[3] WIPO. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int
[4] U.S. Patent and Trademark Office. (2023). Patent Term Adjustment & Extension Policies. Retrieved from https://uspto.gov
